APA (7th ed.) Citation

Xiaoyan Liu, Xiaoyan Liu, Yitian Lang, Qingqing Chai, Yan Lin, Yahui Liao, & Yizhun Zhu. (2022). Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Xiaoyan Liu, Xiaoyan Liu, Yitian Lang, Qingqing Chai, Yan Lin, Yahui Liao, and Yizhun Zhu. Atezolizumab Plus Platinum-based Chemotherapy as First-line Therapy for Metastatic Urothelial Cancer: A Cost-effectiveness Analysis. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Xiaoyan Liu, et al. Atezolizumab Plus Platinum-based Chemotherapy as First-line Therapy for Metastatic Urothelial Cancer: A Cost-effectiveness Analysis. Frontiers Media S.A., 2022.